Skip to content

Establishment of a recruitment pool of prospective subjects and a central control group for studies at the DZNE

Establishment of a recruitment pool of prospective subjects and a central control group for studies at the DZNE - central control group

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00008304
Enrollment
Unknown
Registered
2015-09-23
Start date
2015-08-31
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurodegenerative healthy people

Interventions

Group 1: MMSE, BDI, MRI, blood, urine asservation Depending on the requirements there is a compilation from various instruments to describe the cognitive and / or motor performance, as well as example

Sponsors

Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Written informed consent to participate in the central control group - Knowledge of German, which allows for participation in the planned procedures

Exclusion criteria

Exclusion criteria: - failure of capacity to consent - clinically unstable or serious diseases - diagnosis of a neurodegenerative disease - diagnosis of a cerebro-vascular disease, which explains functional deficits - existing or past passed mental, psychiatric or physical illnesses that preclude their participation as a healthy check on the assessment by the opinion of the study physician-------------------------------------------------- ---------------Exclusion criteria for the optional 3T MRI: - electrical implants such as pacemakers or perfusion pumps - pregnancy and pronounced claustrophobia - concomitant medications that have a strong sedating effect - presence of ferromagnetic or electrically conductive implants such as aneurysm clips, surgical clips, prostheses, artificial hearts, flaps with metal parts, metal pieces, large tattoos, permanent makeup or steel implants

Design outcomes

Primary

MeasureTime frame
Building a central control group for studies of DZNE

Secondary

MeasureTime frame
MMSE, BDI

Countries

Germany

Contacts

Public ContactVerena Pross

Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE)

verena.pross@dzne.de0228 43302 838

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026